NYSE - Nasdaq Real Time Price USD

Hims & Hers Health, Inc. (HIMS)

Time to buy HIMS?

51.96

+0.56

+(1.09%)

At close: May 9 at 4:00:02 PM EDT

51.83

-0.13

(-0.25%)

After hours: May 9 at 7:59:48 PM EDT

Time to buy HIMS?

Hims & Hers Health (NYSE:HIMS) Appoints Mo Elshenawy As New CTO For AI-Driven Healthcare Transformation

Hims & Hers Health (NYSE:HIMS) experienced a remarkable 97% share price increase over the past month, a move that coincided with significant executive changes. The appointment of Mo Elshenawy as Chief Technology Officer to spearhead AI initiatives and Nader Kabbani's new role as Chief Operations Officer may have instilled investor confidence. Strong Q1 2025 earnings results, with substantial growth in sales and net income, likely bolstered this sentiment. In addition, the strategic...

Simply Wall St. 2 days ago

HIMS
+1.09%
Three Stocks That May Be Trading Below Their Estimated Value

The United States market has shown positive momentum, with a 1.3% increase over the last week and an 8.2% rise over the past year, while earnings are expected to grow by 14% annually. In this environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for growth as these companies might be poised to benefit from improving market conditions.

Simply Wall St. 2 days ago

HIMS
+1.09%

CPNG

TTEK
Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS)

Hims & Hers Health (HIMS) is outperforming and posting numbers that make you wonder why anyone still doubts the stock’s longevity. Bears have long scoffed at its telehealth model, hammering the stock down to $25 just last month. Yet yesterday’s Q1 results were a masterclass in defiance, with eye-popping revenue and profit growth that sent shorts scrambling. Stock bears are still hanging on, but given how cheap the stock has become, a run towards $100 per share may be coming sooner than most expe

TipRanks 2 days ago

HIMS
+1.09%

NONOF

NVO
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

SAN FRANCISCO, May 09, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced the pricing of its offering of $870,000,000 aggregate principal amount of 0.00% convertible senior notes due 2030 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering size was increased from the previously announced offering size

Business Wire 2 days ago

HIMS
+1.09%
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

SAN FRANCISCO, May 08, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hims & Hers also expects to grant the initial pur

Business Wire 3 days ago

HIMS
+1.09%
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

SAN FRANCISCO, May 08, 2025--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with deep expertise in artificial intelligence and large-scale infrastructure, as the company’s new Chief Technology Officer. His appointment marks a key milestone as Hims & Hers accelerates its vision to build the next-generation healthcare platform, powered by AI and designed to deliver deeply personalized,

Business Wire 3 days ago

HIMS
+1.09%
Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations

Hims & Hers Health ( NYSE:HIMS ) First Quarter 2025 Results Key Financial Results Revenue: US$586.0m (up 111% from 1Q...

Simply Wall St. 4 days ago

HIMS
+1.09%
Novo Nordisk beats on Q1 earnings, cuts 2025 outlook

Novo Nordisk reported moderate earnings and cut its 2025 outlook.

Yahoo Finance 3 days ago

LLY

HIMS
+1.09%

NONOF
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth

The stock of Hims & Hers Health Inc. (HIMS) fell more than 4% in after-hours trading after the telehealth company issued weaker-than-expected guidance. The cautious outlook overshadowed an impressive 111% year-over-year jump in Q1 revenue, which reached $586 million. Looking ahead, the company expects revenue between $530 million and $550 million in Q2, falling below analysts’ forecast of $563.9 million. Year-to-date, HIMS stock has climbed more than 70%. Notably, shares have surged over 40% fol

TipRanks 4 days ago

NONOF

NVO

HIMS
+1.09%
Stocks Fall as Tariff Angst Spurs Gains in Bonds: Markets Wrap

(Bloomberg) -- Wall Street’s risk-off mode prevailed in the run-up to the Federal Reserve decision, with stocks falling and bonds rising as President Donald Trump’s tariff remarks failed to ease worries that his trade war will cause economic damage.Most Read from BloombergThe Battle Over the Fate of Detroit’s Renaissance CenterNYC Real Estate Industry Asks Judge to Block New Broker Fee LawVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchIceland Plans for a More Volcanic FutureNJ Tr

Bloomberg 5 days ago

RIVN

JPM

BAC
Leading Weight-Loss Stock, Hims & Hers, Shrugs Off Outlook Worries And Spikes 18%

Hims stock reversed higher Tuesday after the telehealth platform issued a lackluster outlook for the current three-month period.

Investor's Business Daily 5 days ago

HIMS
+1.09%

NONOF

NVO
Stock Market Today: Dow Jones, S&P 500 Fall Again; Gold Stocks Rally While Palantir Tumbles (Live Coverage)

The major indexes held on to large losses in the final hour of trading Tuesday. But gold stocks rallied.

Investor's Business Daily 5 days ago

HIMS
+1.09%

VRTX

PLTR
Veracyte Stock Earns Relative Strength Rating Upgrade

Veracyte stock had its Relative Strength (RS) Rating upgraded from 70 to 76 Tuesday — a welcome improvement, but still short of the 80 or better score you prefer to see. Can You Really Time The Stock Market? IBD's unique RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.

Investor's Business Daily 5 days ago

VCYT

HIMS
+1.09%

IRTC
Hims surges, SolarEdge earnings beat, Rivian expands in Illinois

Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Hims & Hers Health (HIMS) seeing a bump higher in its stock price despite disappointing on guidance, SolarEdge Technologies' (SEDG) first quarter earnings beat, and electric vehicle maker Rivian (RIVN) planning to build out a supplier park in Normal, Illinois. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 5 days ago

SEDG

HIMS
+1.09%

RIVN
Trending tickers: Palantir, Ford, Skechers, Deliveroo and BP

The latest investor updates on stocks that are trending on Tuesday.

Yahoo Finance UK 5 days ago

^IXIC

PHG

RYLPF
Hims & Hers Health Revenue Jumps, But Outlook Disappoints

Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook missed Wall Street’s expectations.

The Wall Street Journal 6 days ago

HIMS
+1.09%
Hims & Hers stock slips on disappointing Q2 revenue outlook

Shares of Hims & Hers Health traded slightly lower in after-hours trading. The company reported first quarter revenue of $586.0 million compared to the expected $538.2 million. Wall Street is likely disappointed in the second quarter revenue forecast of $530 million to $550 million. Analysts had been expecting $563.9 million. Market Domination Overtime Anchors Julie Hyman and Josh Lipton are joined by Senior Healthcare Reporter Anjalee Khemlani to discuss the results. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 6 days ago

HIMS
+1.09%
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

SAN FRANCISCO, May 05, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2025, in a shareholder letter that is posted at investors.hims.com.

Business Wire 6 days ago

HIMS
+1.09%
Progyny Stock Sees RS Rating Improve To 73

A Relative Strength Rating upgrade for Progyny shows improving technical performance. Will it continue?

Investor's Business Daily 6 days ago

HIMS
+1.09%

OPCH

PGNY
Hims & Hers Names New COO. Stock Rallies.

Hims stock rose Monday after the telehealth program named technology industry veteran Nader Kabbani as its new chief operating officer.

Investor's Business Daily 6 days ago

HIMS
+1.09%

Performance Overview

Return	HIMS	S&P 500 (^GSPC)
YTD	+114.89%	-3.77%
1-Year	+302.17%	+8.55%
3-Year	+1,300.54%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health (NYSE:HIMS) Appoints Mo Elshenawy As New CTO For AI-Driven Healthcare Transformation

Three Stocks That May Be Trading Below Their Estimated Value

Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS)

Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations

Novo Nordisk beats on Q1 earnings, cuts 2025 outlook

Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth

Stocks Fall as Tariff Angst Spurs Gains in Bonds: Markets Wrap

Leading Weight-Loss Stock, Hims & Hers, Shrugs Off Outlook Worries And Spikes 18%

Stock Market Today: Dow Jones, S&P 500 Fall Again; Gold Stocks Rally While Palantir Tumbles (Live Coverage)

Veracyte Stock Earns Relative Strength Rating Upgrade

Hims surges, SolarEdge earnings beat, Rivian expands in Illinois

Trending tickers: Palantir, Ford, Skechers, Deliveroo and BP

Hims & Hers Health Revenue Jumps, But Outlook Disappoints

Hims & Hers stock slips on disappointing Q2 revenue outlook

Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

Progyny Stock Sees RS Rating Improve To 73

Hims & Hers Names New COO. Stock Rallies.

Performance Overview